You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

tno155

Showing 1 - 7 of 7
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Renal Impairment Trial (TNO155)

Not yet recruiting
  • Renal Impairment
  • TNO155
  • (no location specified)
Sep 16, 2022

Hepatic Impairment Trial (TNO155)

Not yet recruiting
  • Hepatic Impairment
  • TNO155
  • (no location specified)
Aug 4, 2022

Non-small Cell Lung Carcinoma, Head and Neck Squamous Cell Carcinoma, Esophageal SCC Trial in Worldwide (TNO155, Spartalizumab,

Recruiting
  • Non-small Cell Lung Carcinoma
  • +4 more
  • TNO155
  • +2 more
  • Boston, Massachusetts
  • +8 more
Mar 18, 2022

Advanced Cancer, Metastatic Cancer, Malignant Neoplastic Disease Trial in United States (MRTX849, TNO155)

Active, not recruiting
  • Advanced Cancer
  • +2 more
  • Los Angeles, California
  • +11 more
Nov 12, 2021

Lung Cancer, Anaplastic Lymphoma Kinase Gene Translocation, ROS1 Rearrangement Trial in Boston (Lorlatinib, Crizotinib,

Recruiting
  • Lung Cancer
  • +6 more
  • Boston, Massachusetts
  • +1 more
Mar 7, 2021

KRAS G12C Mutant Solid Tumors, NSCLC, Carcinoma, Colorectal Trial in Worldwide (JDQ443, TNO155, tislelizumab)

Recruiting
  • KRAS G12C Mutant Solid Tumors
  • +9 more
  • Atlanta, Georgia
  • +31 more
Jul 7, 2022

NSCLC, Colorectal Neoplams, Endometrial Tumors Trial in Worldwide (LY3537982, Abemaciclib, Erlotinib)

Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • +4 more
  • Los Angeles, California
  • +21 more
Jul 22, 2022